Cowen Inc. lifted its stake in shares of Monsanto Company (NYSE:MON) by 152.6% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 107,800 shares of the basic materials company’s stock after buying an additional 312,900 shares during the period. Monsanto makes up approximately 0.5% of Cowen Inc.’s investment portfolio, making the stock its 24th biggest holding. Cowen Inc.’s holdings in Monsanto were worth $12,917,000 at the end of the most recent reporting period.
Several other large investors also recently bought and sold shares of the company. Vanguard Group Inc. raised its holdings in shares of Monsanto by 2.6% during the second quarter. Vanguard Group Inc. now owns 30,725,725 shares of the basic materials company’s stock worth $3,636,697,000 after purchasing an additional 784,418 shares during the last quarter. BlackRock Inc. raised its holdings in shares of Monsanto by 6.5% during the second quarter. BlackRock Inc. now owns 27,898,255 shares of the basic materials company’s stock worth $3,302,038,000 after purchasing an additional 1,705,439 shares during the last quarter. State Street Corp raised its holdings in shares of Monsanto by 0.6% during the second quarter. State Street Corp now owns 20,276,780 shares of the basic materials company’s stock worth $2,399,965,000 after purchasing an additional 122,814 shares during the last quarter. Northern Trust Corp raised its holdings in shares of Monsanto by 0.7% during the second quarter. Northern Trust Corp now owns 7,092,929 shares of the basic materials company’s stock worth $839,519,000 after purchasing an additional 47,725 shares during the last quarter. Finally, Flossbach Von Storch AG raised its holdings in shares of Monsanto by 7.5% during the second quarter. Flossbach Von Storch AG now owns 4,397,000 shares of the basic materials company’s stock worth $520,429,000 after purchasing an additional 307,600 shares during the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.
Several research analysts recently issued reports on MON shares. Zacks Investment Research cut shares of Monsanto from a “buy” rating to a “hold” rating in a report on Tuesday, September 12th. Wells Fargo & Company raised their target price on shares of Monsanto from $107.50 to $118.00 and gave the stock a “market perform” rating in a report on Tuesday, October 10th. UBS cut shares of Monsanto from a “buy” rating to a “neutral” rating and set a $128.00 target price for the company. in a report on Friday, August 18th. BidaskClub raised shares of Monsanto from a “sell” rating to a “hold” rating in a report on Saturday, August 19th. Finally, Barclays reaffirmed an “equal weight” rating and issued a $124.00 price objective (up previously from $120.00) on shares of Monsanto in a report on Thursday, October 5th. Eleven analysts have rated the stock with a hold rating and four have given a buy rating to the company. Monsanto has an average rating of “Hold” and a consensus target price of $124.61.
Monsanto Company (NYSE MON) traded down $0.18 on Thursday, reaching $118.08. 1,376,600 shares of the company’s stock were exchanged, compared to its average volume of 1,959,747. Monsanto Company has a one year low of $104.08 and a one year high of $122.79. The company has a quick ratio of 0.83, a current ratio of 1.35 and a debt-to-equity ratio of 1.12. The stock has a market capitalization of $52,058.05, a PE ratio of 21.39, a price-to-earnings-growth ratio of 1.70 and a beta of 1.04.
Monsanto (NYSE:MON) last released its earnings results on Wednesday, October 4th. The basic materials company reported $0.20 EPS for the quarter, topping analysts’ consensus estimates of ($0.41) by $0.61. The business had revenue of $2.69 billion during the quarter, compared to analysts’ expectations of $2.51 billion. Monsanto had a net margin of 15.44% and a return on equity of 42.40%. The company’s quarterly revenue was up 4.8% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.07 earnings per share. analysts predict that Monsanto Company will post 5.74 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Friday, January 5th will be paid a dividend of $0.54 per share. The ex-dividend date is Thursday, January 4th. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.83%. Monsanto’s dividend payout ratio is currently 42.27%.
In other news, CFO Pierre Courduroux sold 4,320 shares of the business’s stock in a transaction dated Thursday, October 19th. The shares were sold at an average price of $122.00, for a total transaction of $527,040.00. Following the completion of the sale, the chief financial officer now owns 48,388 shares of the company’s stock, valued at $5,903,336. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Nicole M. Ringenberg sold 7,890 shares of the business’s stock in a transaction dated Monday, October 16th. The stock was sold at an average price of $122.25, for a total transaction of $964,552.50. Following the sale, the vice president now directly owns 38,600 shares of the company’s stock, valued at approximately $4,718,850. The disclosure for this sale can be found here. Insiders have sold 49,236 shares of company stock valued at $5,931,934 in the last three months. Corporate insiders own 0.79% of the company’s stock.
WARNING: This news story was originally published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this news story on another publication, it was illegally copied and republished in violation of U.S. & international copyright and trademark law. The original version of this news story can be read at https://ledgergazette.com/2017/12/07/cowen-inc-boosts-stake-in-monsanto-company-mon.html.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.